Modulation of Inflammation in Osteoarthritis via CD14-mediated pattern recognition
通过 CD14 介导的模式识别调节骨关节炎炎症
基本信息
- 批准号:10052718
- 负责人:
- 金额:$ 49.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAnalgesicsAnti-Inflammatory AgentsArthralgiaArthritisBehaviorBiologyBlocking AntibodiesBone MarrowBone remodelingCD14 AntigenCD14 geneCartilageCell Differentiation processCellsCharacteristicsChimera organismChronicCoupledCytometryDegenerative polyarthritisDependenceDeteriorationDevelopmentDiseaseDisease ProgressionEffectivenessFatty acid glycerol estersFunctional disorderFutureGeneticHematopoieticHematopoietic SystemHyperalgesiaImageImmuneImmunologyIn VitroInfectionInfiltrationInflammationInflammation MediatorsInflammatoryInjectionsInjuryJointsKneeKnee InjuriesKnee OsteoarthritisLaboratoriesLeadLeukocytesLigandsLiquid substanceMeasuresMedial meniscus structureMediatingMediator of activation proteinMedicalModelingMolecularMusMyelogenousMyeloid CellsNeuronsNociceptionOpioidOsteitisOsteoclastsOutcomePainPathologicPathologyPathway interactionsPatientsPattern RecognitionPattern recognition receptorPharmaceutical PreparationsPharmacologyPositioning AttributeProductionQuality of lifeReagentReceptor SignalingRegulationRehabilitation therapyReplacement ArthroplastyResearch PersonnelRoleSeveritiesSignal TransductionSpecific qualifier valueSpinal GangliaStimulusSymptomsSynovial MembraneTechniquesTestingTherapeuticTissuesToll-like receptorsTreatment EfficacyTreatment ProtocolsWorkarthropathiesbonecell typecellular targetingclinical translationcostdesigndisabilityexperimental studyimprovedin vivoinflammatory paininterdisciplinary approachjoint destructionjoint injurymacrophagemonocytemouse modelmutantnew therapeutic targetnovel strategiesosteoarthritis painpain behaviorpain reductionpressurepreventreceptorreceptor-mediated signalingrelease of sequestered calcium ion into cytoplasmresponsesensorside effecttargeted treatmenttherapeutic developmenttherapeutic evaluationtissue injury
项目摘要
ABSTRACT
Osteoarthritis (OA) is a leading cause of disability in adults, causing chronic progressive joint pain and tissue
damage throughout the joint. No current medical treatments are effective at preventing the progressive joint
deterioration, pain and disability characteristic of OA. Although it is known that inflammation and bone-
remodeling are major drivers of OA pain and pathology, it is not yet clear which molecular pathways directly
drive chronic OA pain and disease progression or are key targets for therapeutic development. Our lab has
shown that deficiency of CD14, an inflammatory pattern-recognition receptor expressed by macrophages and
other myeloid cell types, protects against OA-associated bone-remodeling and pain-related joint dysfunction
after knee injury in mice. In patients, CD14 is increased in joint fluid and associated with intra-articular
macrophage infiltration as well as pain severity. This receptor facilitates Toll-like receptor (TLR) signaling.
TLRs are innate immune sensors which are important initial triggers of chronic inflammation in response to
non-infectious tissue damage. In addition, our team has recently demonstrated that TLR-signaling is critical to
development of knee OA pain in mice, via direct stimulation of pain-transmitting (nociceptive) neurons in the
dorsal root ganglia (DRG) that innervate the knee. In this proposal, we will test the hypothesis that CD14 on
myeloid cells including macrophages promotes OA pain-related pathology (bone remodelling and
inflammation), while CD14 also augments OA pain by directly sensitizing neurons innervating the
arthritic joint. We will utilize in vitro techniques and the murine destabilization of the medial meniscus (DMM)
model of OA, to understand the cellular and molecular mechanisms by which CD14 drives OA pathology and
inflammation in joint tissues. Specifically, in Aim 1 we will use a multi-disciplinary approach to determine how
genetic deficiency of CD14 modifies inflammation and bone-remodeling during progression of OA, using the
DMM model. We will determine the contribution of myeloid cells to inflammation and bone-remodeling in the
model by using bone marrow (BM) chimeric mice. Lastly, we will test the effects of CD14 on differentiation of
cells that drive bone-remodeling (osteoclasts) and production of inflammatory mediators of pain from myeloid
cell types. In Aim 2 we will characterize effects of CD14 on TLR-mediated DRG neuronal activation and joint
pain. We will use TLR stimuli with relevance to OA to evaluate DRG responses in vitro, comparing WT and
CD14-deficient cells. We will additionally compare pain responses to injection of TLR-stimuli into the joint, and
expect that both DRG responses and pain will be blunted in the CD14 deficient strain. Finally, in Aim 3 we will
test whether pharmacological targeting of CD14 reduces OA progression and pain after DMM-induced injury.
This study will then specify the molecular and cellular framework to design future anti-inflammatory
therapeutics for OA aimed at CD14- and TLR-mediated mechanisms.
抽象的
骨关节炎(OA)是成人残疾的主要原因,导致慢性进行性关节疼痛和组织
整个关节损坏。目前没有医疗治疗可有效防止进行性关节
OA的恶化,疼痛和残疾特征。尽管众所周知炎症和骨
重塑是OA疼痛和病理学的主要驱动因素,目前尚不清楚哪种分子途径直接
驱动慢性OA疼痛和疾病进展,或者是治疗发育的关键靶标。我们的实验室有
表明CD14的不足是巨噬细胞和
其他髓样细胞类型,可以防止与OA相关的骨骼复制和与疼痛相关的关节功能障碍
小鼠膝盖受伤后。在患者中,关节液中的CD14增加并与关节内有关
巨噬细胞浸润以及疼痛的严重程度。该受体促进了Toll样受体(TLR)信号传导。
TLR是先天免疫传感器,这是慢性炎症的重要初始触发因素。
非感染组织损伤。此外,我们的团队最近证明了TLR信号对
通过直接刺激疼痛传递(伤害感受)神经元的膝关节疼痛的发育
支撑膝盖的背根神经节(DRG)。在此提案中,我们将测试CD14上的假设
髓样细胞在内
炎症),而CD14也通过直接使神经元支配神经来增加OA疼痛
关节炎关节。我们将利用体外技术和内侧半月板的鼠不稳定(DMM)
OA的模型,了解CD14驱动OA病理学和的细胞和分子机制
关节组织中的炎症。具体而言,在AIM 1中,我们将使用多学科的方法来确定如何
CD14的遗传缺乏可修饰OA进展过程中的炎症和骨骼复制,并使用
DMM型号。我们将确定髓样细胞对在炎症和骨造成的贡献
使用骨髓(BM)嵌合小鼠进行模型。最后,我们将测试CD14对分化的影响
驱动骨骼复制的细胞(破骨细胞)和髓样疼痛炎症介质的产生
细胞类型。在AIM 2中,我们将表征CD14对TLR介导的DRG神经元激活和关节的影响
疼痛。我们将使用与OA相关的TLR刺激来评估体外DRG响应,比较WT和WT
CD14缺陷细胞。我们还将比较将TLR刺激注射到关节中的疼痛反应,并将其进行比较
预计DRG反应和疼痛都会在CD14缺乏菌株中钝化。最后,在目标3中,我们将
测试CD14的药理靶向是否会减少DMM诱导损伤后的OA进展和疼痛。
然后,这项研究将指定分子和细胞框架以设计未来的抗炎
OA针对CD14和TLR介导的机制的治疗剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carla Rose Scanzello其他文献
Carla Rose Scanzello的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carla Rose Scanzello', 18)}}的其他基金
Achieving Sustained Control of Inflammation to Prevent Post-Traumatic Osteoarthritis (PTOA)
实现炎症的持续控制以预防创伤后骨关节炎 (PTOA)
- 批准号:
10641225 - 财政年份:2023
- 资助金额:
$ 49.39万 - 项目类别:
Targeting Cellular Mechanosensing to Alleviate Joint Stiffness in Synovial Fibrosis
靶向细胞机械传感减轻滑膜纤维化引起的关节僵硬
- 批准号:
10657546 - 财政年份:2022
- 资助金额:
$ 49.39万 - 项目类别:
BCCMA: Cartilage Repair Strategies to Alleviate Arthritis Pain (Care AP): Targeting Pattern-Recognition to Reduce Pain-Related Pathology in Osteoarthritis
BCCMA:缓解关节炎疼痛的软骨修复策略(Care AP):以模式识别为目标,减少骨关节炎中与疼痛相关的病理
- 批准号:
10620628 - 财政年份:2022
- 资助金额:
$ 49.39万 - 项目类别:
Targeting Cellular Mechanosensing to Alleviate Joint Stiffness in Synovial Fibrosis
靶向细胞机械传感减轻滑膜纤维化引起的关节僵硬
- 批准号:
10475464 - 财政年份:2022
- 资助金额:
$ 49.39万 - 项目类别:
BCCMA: Cartilage Repair Strategies to Alleviate Arthritis Pain (Care AP): Targeting Pattern-Recognition to Reduce Pain-Related Pathology in Osteoarthritis
BCCMA:缓解关节炎疼痛的软骨修复策略(Care AP):以模式识别为目标,减少骨关节炎中与疼痛相关的病理
- 批准号:
10365346 - 财政年份:2022
- 资助金额:
$ 49.39万 - 项目类别:
Modulation of Inflammation in Osteoarthritis via CD14-mediated pattern recognition
通过 CD14 介导的模式识别调节骨关节炎炎症
- 批准号:
10224102 - 财政年份:2020
- 资助金额:
$ 49.39万 - 项目类别:
Modulation of Inflammation in Osteoarthritis via CD14-mediated pattern recognition
通过 CD14 介导的模式识别调节骨关节炎炎症
- 批准号:
10450671 - 财政年份:2020
- 资助金额:
$ 49.39万 - 项目类别:
Modulation of Inflammation in Osteoarthritis via CD14-mediated pattern recognition
通过 CD14 介导的模式识别调节骨关节炎炎症
- 批准号:
10669024 - 财政年份:2020
- 资助金额:
$ 49.39万 - 项目类别:
相似国自然基金
芳基氨甲基-哌啶/四氢萘类μ/δ阿片受体双重功效镇痛分子成药性研究
- 批准号:81773635
- 批准年份:2017
- 资助金额:48.0 万元
- 项目类别:面上项目
长效阿片类镇痛药物镇痛与依赖分离的机制研究
- 批准号:81402911
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
运用代谢组学技术系统研究乌头碱类镇痛药的体内活性/毒性代谢产物
- 批准号:81302844
- 批准年份:2013
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
δ、μ、κ 阿片受体三重激动剂的作用机制研究
- 批准号:81173029
- 批准年份:2011
- 资助金额:14.0 万元
- 项目类别:面上项目
去甲肾上腺素α2A受体的镇痛调节新靶点- - -CSK
- 批准号:81072626
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
相似海外基金
Novel models to study dorsal root ganglion neurons in knee osteoarthritis pain
研究膝骨关节炎疼痛中背根神经节神经元的新模型
- 批准号:
10783393 - 财政年份:2023
- 资助金额:
$ 49.39万 - 项目类别:
Development of a phenotypic screening assay for novel compounds that inhibit peripheral pain-sensing neurons
开发抑制外周痛觉神经元的新型化合物的表型筛选试验
- 批准号:
10650640 - 财政年份:2023
- 资助金额:
$ 49.39万 - 项目类别:
Non-SteroidAl Impact on Kidney Disease Study (NSAIDS)
非类固醇对肾脏疾病的影响研究 (NSAIDS)
- 批准号:
10655205 - 财政年份:2023
- 资助金额:
$ 49.39万 - 项目类别:
Designed Multiple Ligands as Non-opioid Analgesics for Treating Chronic Pain
设计多种配体作为非阿片类镇痛药,用于治疗慢性疼痛
- 批准号:
10621646 - 财政年份:2023
- 资助金额:
$ 49.39万 - 项目类别:
Brainstem Trigeminal Mechanisms of Orofacial Pain
口面部疼痛的脑干三叉神经机制
- 批准号:
10598592 - 财政年份:2022
- 资助金额:
$ 49.39万 - 项目类别: